Get the Stockscreener App
378.89
0.11%
-0.40
Pre-market:
377.42
-1.47
-0.39%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Waters Corp stock is traded at $378.89, with a volume of 731.36K.
It is down -0.11% in the last 24 hours and up +3.70% over the past month.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
See More
Previous Close:
$379.29
Open:
$369.835
24h Volume:
731.36K
Relative Volume:
0.71
Market Cap:
$37.20B
Revenue:
$3.77B
Net Income/Loss:
$449.25M
P/E Ratio:
48.23
EPS:
7.8556
Net Cash Flow:
$240.68M
1W Performance:
+2.72%
1M Performance:
+3.70%
6M Performance:
-5.41%
1Y Performance:
+8.19%
1-Day Range:
$369.45
$380.35
1-Week Range:
$364.44
$382.35
52-Week Range:
$275.05
$414.15
Waters Corp Stock (WAT) Company Profile
Name
Waters Corp
Sector
Industry
Phone
(508) 478-2000
Address
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
378.89 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
TMO
Thermo Fisher Scientific Inc
|
517.60 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
193.62 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
564.98 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
283.80 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-06-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-10-26 | Resumed | Citigroup | Buy |
| Feb-10-26 | Resumed | Evercore ISI | In-line |
| Jan-06-26 | Initiated | Guggenheim | Buy |
| Jan-05-26 | Initiated | William Blair | Outperform |
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Mar-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-26-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Nov-13-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| May-18-22 | Initiated | Barclays | Overweight |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-25-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-07-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-17-20 | Upgrade | Cleveland Research | Underperform → Buy |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-28-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Jul-16-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-08-20 | Downgrade | Needham | Hold → Underperform |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Sell |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-09-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Jul-16-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-12-19 | Downgrade | Cleveland Research | Neutral → Underperform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| Jan-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-03-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-03-19 | Initiated | Needham | Hold |
| Dec-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-11-18 | Upgrade | Cleveland Research | Sell → Neutral |
View All
Waters Corp Stock (WAT) Latest News
Waters Corporation highlights analytical science role amid steady industry demand - AD HOC NEWS
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp. stock underperforms Monday when compared to competitors - MarketWatch
Waters Corporation with a clear analyst view, shares trade steadily on the NYSE - AD HOC NEWS
ACQUITY Premier System from Waters Corpmetal free flow path for tougher separations - AD HOC NEWS
Waters Corp (WAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bernstein SocGen resumes Waters stock coverage with outperform rating - Investing.com UK
Waters (WAT) Receives Outperform Rating with $435 Target from Be - GuruFocus
Bernstein SocGen resumes Waters stock coverage with outperform rating By Investing.com - Investing.com Australia
WAT Reinstated by Bernstein -- Rating Upgraded to Outperform - GuruFocus
Waters Corporation clears a fresh analyst mark, shares trade higher on Xetra and NYSE - AD HOC NEWS
Form 4 Waters Corporation For: 25 June By Investing.com - Investing.com Australia
Waters (NYSE: WAT) SVP has 189 shares withheld to cover RSU tax - Stock Titan
Waters Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
SNT Biotech Announces a Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients - StreetInsider
Waters, IMU Biosciences partner to accelerate AI immune mapping for precision medicineVietnam Investment Review - Vietnam Investment Review - VIR
Waters Corp (WAT) Stock Up 3.4% and Still Undervalued -- GF Scor - GuruFocus
Waters Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
IMU Biosciences, Waters form AI immunology partnership - Investing.com
Waters backs IMU’s AI blood test platform for cancer and other diseases - Stock Titan
Waters Corporation (WAT): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Waters Corp (WAT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Waters Corp (WAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Waters opens the week with earnings focus, shares on NYSE - AD HOC NEWS
Waters Corporation stock: Is WAT underperforming the health care sector? - MSN
Xevo TQ-XS Mass Spectrometer from Waters Corphighly sensitive LC-MS/MS for demanding labs - AD HOC NEWS
Waters StockSunday background on lab-analytics specialist - Ad-hoc-news.de
Precision workflows in the lab, Waters Xevo TQ Absolute quietly pushes LC-MS sensitivity - AD HOC NEWS
Smart workflows at the bench, Waters ACQUITY Arc Bio helps labs keep up - AD HOC NEWS
Subtle but forensic, Waters ACQUITY Premier UHPLC targets stubborn metals - AD HOC NEWS
Waters Corp (WAT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Waters Corp (WAT) Institutional Confidence - TradingKey
Waters Corp (WAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Waters Corp (WAT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Waters Corp (WAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Waters Corp (WAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Waters Corporation Stock: Is WAT Underperforming the Health Care Sector? - Barchart.com
Waters Corp (NYSE:WAT) Technical Setup Signals High-Quality Breakout Opportunity - ChartMill
Waters Arc Premier System targets demanding labs with precision and uptime gains - AD HOC NEWS
Waters Corporation Stock (US9418481035): New product launches keep the stock in focus - Ad-hoc-news.de
Battery safety testing gets a sharper edge with Waters' Coin Cell DSC - AD HOC NEWS
Meridiem Capital Partners LP's Waters Corp(WAT) Holding History - GuruFocus
Waters Corporation Stock (US9418481035): Fundamentals and valuation under the microscope - Ad-hoc-news.de
Waters Launches New Tools As Investors Weigh Biologics And Battery Upside - Yahoo Finance
Waters Corp. stock outperforms competitors despite losses on the day - MarketWatch
Waters Corporation ACQUITY Premier System: UHPLC workhorse for demanding labs - AD HOC NEWS
Calvert U.S. Mid Cap Core Responsible Index Fund's Waters Corp(WAT) Holding History - GuruFocus
Abraham Fortress Fund's Waters Corp(WAT) Holding History - GuruFocus
Westchester Capital Management, Inc.'s Waters Corp(WAT) Holding History - GuruFocus
Waters targets earlier thermal runaway detection with whole-cell coin cell differential scanning calorimeter - R&D World
Waters Corp Stock (WAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Waters Corp Stock (WAT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FEARON RICHARD H | Director |
Mar 06 '26 |
Buy |
306.34 |
1,000 |
306,340 |
3,302 |
| KUEBLER CHRISTOPHER A | Director |
Nov 05 '25 |
Option Exercise |
130.35 |
3,761 |
490,246 |
18,796 |
0.07%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):